BluSense

BluSense is a Danish biotechnology company producing diagnostic devices for point-of-care testing. IDTechEx caught up with BluSense at Medica 2022, where the company was exhibiting its technology.

BluSense Diagnostics is an in vitro diagnostics company with core technology in microfluidics and immuno-magnetic assays for point-of-care testing of infectious diseases. IDTechEx analyst Andy Ko spoke with BluSense CEO Maarten van der Linden and CSO Dr Marco Donolato on 29/10/2021.